| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.15B | +23.4% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 18.8% | Net margin -12.6% |
| Revenue Q/Q | -18.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.12B | 81.2% |
| R&D | ¥0.01B | 7.5% |
| SG&A | ¥0.03B | 18.2% |
| Tax & other | ¥-0.00B | -1.8% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
迈克生物 ・ 星徽股份 ・ 高伟达 ・ 赛摩智能 ・ 迅游科技 ・ 四方精创 ・ 信息发展 ・ 中密控股 ・ 厚普股份 ・ *ST新元 ・ 德尔股份 ・ 景嘉微
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies